Clear Cell Renal Cell Carcinoma 2021-2022 / / edited by Claudia Manini, José I. López.
Clear cell renal cell carcinoma is currently one of the most interesting areas of study in oncology. Despite the advances made in this field, this tumor continues to be a health problem of major concern in Western societies, seriously affecting public health services. Several characteristics of this...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (342 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993567752404498 |
---|---|
ctrlnum |
(CKB)5860000000259572 (NjHacI)995860000000259572 (EXLCZ)995860000000259572 |
collection |
bib_alma |
record_format |
marc |
spelling |
Clear Cell Renal Cell Carcinoma 2021-2022 / edited by Claudia Manini, José I. López. Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022. 1 online resource (342 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Clear cell renal cell carcinoma is currently one of the most interesting areas of study in oncology. Despite the advances made in this field, this tumor continues to be a health problem of major concern in Western societies, seriously affecting public health services. Several characteristics of this tumor make it an exciting meeting point for translational collaboration between clinicians and basic researchers. Clear cell renal cell carcinoma is a paradigmatic example of inter- and intra-tumor heterogeneity from morphological, immunohistochemical, and molecular viewpoints. This tumor is also a good example to investigate the complexity of tumor/tumor and tumor/environment relationships from an ecological perspective. A deeper identification of the varied internal tumor self-organization through the specialization of cell clones and subclones as local invaders and metastasizers, on one hand, and the interactions of specific subsets of tumor cells with the local host microenvironment, on the other, will significantly enrich our knowledge of this neoplasm. Clear cell renal cell carcinoma is also a paradigmatic test bench for antiangiogenic and immune checkpoint blockage therapies. The refinement of these therapeutic tools administered alone or in combination is a hot issue in oncology, and several international trials are underway. In English. Clinical medicine. Medicine Practice. 3-0365-5518-8 Manini, Claudia, editor. López, José I., editor. |
language |
English |
format |
eBook |
author2 |
Manini, Claudia, López, José I., |
author_facet |
Manini, Claudia, López, José I., |
author2_variant |
c m cm j i l ji jil |
author2_role |
TeilnehmendeR TeilnehmendeR |
title |
Clear Cell Renal Cell Carcinoma 2021-2022 / |
spellingShingle |
Clear Cell Renal Cell Carcinoma 2021-2022 / |
title_full |
Clear Cell Renal Cell Carcinoma 2021-2022 / edited by Claudia Manini, José I. López. |
title_fullStr |
Clear Cell Renal Cell Carcinoma 2021-2022 / edited by Claudia Manini, José I. López. |
title_full_unstemmed |
Clear Cell Renal Cell Carcinoma 2021-2022 / edited by Claudia Manini, José I. López. |
title_auth |
Clear Cell Renal Cell Carcinoma 2021-2022 / |
title_new |
Clear Cell Renal Cell Carcinoma 2021-2022 / |
title_sort |
clear cell renal cell carcinoma 2021-2022 / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2022 |
physical |
1 online resource (342 pages) |
isbn |
3-0365-5518-8 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC48 |
callnumber-sort |
RC 248 C543 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616 |
dewey-sort |
3616 |
dewey-raw |
616 |
dewey-search |
616 |
work_keys_str_mv |
AT maniniclaudia clearcellrenalcellcarcinoma20212022 AT lopezjosei clearcellrenalcellcarcinoma20212022 |
status_str |
n |
ids_txt_mv |
(CKB)5860000000259572 (NjHacI)995860000000259572 (EXLCZ)995860000000259572 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Clear Cell Renal Cell Carcinoma 2021-2022 / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1764995116492128256 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02382nam a2200313 i 4500</leader><controlfield tag="001">993567752404498</controlfield><controlfield tag="005">20230329181759.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230329s2022 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5860000000259572</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995860000000259572</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995860000000259572</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC48</subfield><subfield code="b">.C543 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Clear Cell Renal Cell Carcinoma 2021-2022 /</subfield><subfield code="c">edited by Claudia Manini, José I. López.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (342 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Clear cell renal cell carcinoma is currently one of the most interesting areas of study in oncology. Despite the advances made in this field, this tumor continues to be a health problem of major concern in Western societies, seriously affecting public health services. Several characteristics of this tumor make it an exciting meeting point for translational collaboration between clinicians and basic researchers. Clear cell renal cell carcinoma is a paradigmatic example of inter- and intra-tumor heterogeneity from morphological, immunohistochemical, and molecular viewpoints. This tumor is also a good example to investigate the complexity of tumor/tumor and tumor/environment relationships from an ecological perspective. A deeper identification of the varied internal tumor self-organization through the specialization of cell clones and subclones as local invaders and metastasizers, on one hand, and the interactions of specific subsets of tumor cells with the local host microenvironment, on the other, will significantly enrich our knowledge of this neoplasm. Clear cell renal cell carcinoma is also a paradigmatic test bench for antiangiogenic and immune checkpoint blockage therapies. The refinement of these therapeutic tools administered alone or in combination is a hot issue in oncology, and several international trials are underway.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine</subfield><subfield code="x">Practice.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5518-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manini, Claudia,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">López, José I.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 12:18:18 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-11-14 04:01:55 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5341095230004498&Force_direct=true</subfield><subfield code="Z">5341095230004498</subfield><subfield code="8">5341095230004498</subfield></datafield></record></collection> |